Fundraising Fox
Redshiftbio
Boxborough, US · Founded 2005 · Delaware corporation · 27 employees on LinkedIn · 2 known investors
Find your way into Redshiftbio
Sign up to see every warm intro you have to Redshiftbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Redshiftbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.
Founders & leadership
TO
Thomas O'LenicExecutive
EM
Eugene MaExecutive
CM
Charles MarshallExecutive
Board
FS
WC
William CadoganBoard director
BH
WM
DB
Don BossiBoard director
SH
Susan HolleranBoard director
Investors · 2
Illumina Ventures✓ confirmed by RedshiftbioFoster City
How we know: Illumina Ventures's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$58.1M disclosed across 8 rounds · 2014–2025
▶$5.9MraisedJun 2025 · 8 investors · Other TechnologyRule 506(b)
▶$5.9MraisedJun 2025 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank SmithDirector
- William CadoganDirector
- Bryson HollimonDirector
- Susan HolleranDirector
- Wouter MeulemanDirector
- Thomas O'LenicExecutive Officer, Director
- Offering amount
- $7.1M
- Amount sold
- $5.9M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedApr 2024 · 6 investors · Other TechnologyRule 506(b)
▶$5MraisedApr 2024 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Bryson HollimonDirector
- Mark CafazzoDirector
- William CadoganDirector
- Wouter MeulemanDirector
- Thomas O'LenicExecutive Officer, Director
- Frank SmithDirector
- Amol ChaubalDirector
- Offering amount
- $7M
- Amount sold
- $5M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedOct 2021 · 12 investors · Other TechnologyRule 506(b)
▶$10MraisedOct 2021 · 12 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles PurtellDirector
- Julien BradleyExecutive Officer, Director
- Bryson HollimonDirector
- William CadoganDirector
- Frank SmithDirector
- Amol ChaubalDirector
- Offering amount
- $20M
- Amount sold
- $10M
- Sales commissions
- $275K
- Placement agents
- Bowen Advisors Inc.
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedDec 2020 · 6 investors · Other TechnologyRule 506(b)
▶$6.4MraisedDec 2020 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles PurtellDirector
- William CadoganDirector
- Frank SmithDirector
- Julien BradleyExecutive Officer, Director
- Bryson HollimonDirector
- Rob CarsonDirector
- Offering amount
- $6.4M
- Amount sold
- $6.4M
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$18.3MraisedDec 2019 · 11 investors · Other TechnologyRule 506(b)
▶$18.3MraisedDec 2019 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William CadoganDirector
- Charles MarshallExecutive Officer, Director
- Rob CarsonDirector
- Eugene MaExecutive Officer
- Bryson HollimanDirector
- Frank SmithDirector
- Offering amount
- $18.3M
- Amount sold
- $18.3M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.8MraisedMar 2017 · 10 investors · Other TechnologyRule 506(b)
▶$10.8MraisedMar 2017 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eugene MaExecutive Officer
- Frank SmithDirector
- William CadoganDirector
- Bryson HollimanDirector
- Charles MarshallExecutive Officer, Director
- Offering amount
- $10.8M
- Amount sold
- $10.8M
- Sales commissions
- $250K
- Placement agents
- Bowen Advisors, Inc.
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$998.1KraisedOct 2015 · 4 investors · Other TechnologyRule 506(b)
▶$998.1KraisedOct 2015 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Frank SmithDirector
- Eugene MaExecutive Officer
- William CadoganDirector
- Charles MarshallExecutive Officer, Director
- Bryson HollimonDirector
- Offering amount
- $2M
- Amount sold
- $998.1K
- Minimum investment
- $1
- Proceeds to insiders
- $50.5K
- First sale
- Sep 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$751.5KraisedApr 2014 · 4 investors · Other TechnologyRule 506(b)
▶$751.5KraisedApr 2014 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- William CadoganDirector
- Don BossiDirector
- Bryson HollimonDirector
- Charles MarshallExecutive Officer, Director
- Eugene MaExecutive Officer
- Offering amount
- $1.8M
- Amount sold
- $751.5K
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
OupOxford University Press (OUP) provides dictionary data, language datasets, and lexical content in over 60 languages to power digital literacy tools, educational software, gaming platforms, and media experiences. The company works across reading apps, word games, quiz shows, and broadcast media to expand access to language learning and comprehension.
FiveableFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
IntechopenIntechOpen is an open access publisher of books and open science journals covering science, technology, and medicine, serving academics and researchers across interdisciplinary fields. It also operates a book series model with editorial-board-led topics and a custom manuscript submission and peer review platform.
Companies working in the same space as Redshiftbio.
Frequently asked questions
- What does Redshiftbio do?
- RedShiftBio develops analytical technology that provides real-time measurement of biomolecular structure and concentration, aimed at supporting decisions in biopharmaceutical development and manufacturing.
- Who are Redshiftbio's investors?
- Redshiftbio's investors include Illumina Ventures, Technology Venture Partners.
- How much funding has Redshiftbio raised?
- Redshiftbio has disclosed $58.1M raised across 8 rounds.
- Where is Redshiftbio headquartered?
- Redshiftbio is headquartered in Boxborough, US.